These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 22750007
1. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Bioorg Med Chem; 2012 Aug 01; 20(15):4848-55. PubMed ID: 22750007 [Abstract] [Full Text] [Related]
2. Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of anti-breast cancer agents. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Eur J Pharm Sci; 2012 Aug 30; 47(1):273-9. PubMed ID: 22538055 [Abstract] [Full Text] [Related]
5. Unified multi-target approach for the rational in silico design of anti-bladder cancer agents. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Anticancer Agents Med Chem; 2013 Jun 30; 13(5):791-800. PubMed ID: 23272967 [Abstract] [Full Text] [Related]
6. Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Bioorg Med Chem; 2011 Nov 01; 19(21):6239-44. PubMed ID: 21967806 [Abstract] [Full Text] [Related]
7. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Prado-Prado FJ, González-Díaz H, de la Vega OM, Ubeira FM, Chou KC. Bioorg Med Chem; 2008 Jun 01; 16(11):5871-80. PubMed ID: 18485714 [Abstract] [Full Text] [Related]
8. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H. Bioorg Med Chem; 2009 Jan 15; 17(2):569-75. PubMed ID: 19112024 [Abstract] [Full Text] [Related]
10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y. J Chem Inf Model; 2005 Jan 15; 45(4):1082-100. PubMed ID: 16045304 [Abstract] [Full Text] [Related]
11. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Speck-Planche A, Kleandrova VV, Cordeiro MN. Eur J Pharm Sci; 2013 Mar 12; 48(4-5):812-8. PubMed ID: 23376211 [Abstract] [Full Text] [Related]
14. In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis. Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN. Comb Chem High Throughput Screen; 2012 Sep 12; 15(8):666-73. PubMed ID: 22452349 [Abstract] [Full Text] [Related]
15. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. Prado-Prado F, García-Mera X, Escobar M, Sobarzo-Sánchez E, Yañez M, Riera-Fernandez P, González-Díaz H. Eur J Med Chem; 2011 Dec 12; 46(12):5838-51. PubMed ID: 22005185 [Abstract] [Full Text] [Related]
16. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum. González-Díaz H, Prado-Prado F, Sobarzo-Sánchez E, Haddad M, Maurel Chevalley S, Valentin A, Quetin-Leclercq J, Dea-Ayuela MA, Teresa Gomez-Muños M, Munteanu CR, José Torres-Labandeira J, García-Mera X, Tapia RA, Ubeira FM. J Theor Biol; 2011 May 07; 276(1):229-49. PubMed ID: 21277861 [Abstract] [Full Text] [Related]
17. Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica. Prado-Prado F, García-Mera X, Abeijón P, Alonso N, Caamaño O, Yáñez M, Gárate T, Mezo M, González-Warleta M, Muiño L, Ubeira FM, González-Díaz H. Eur J Med Chem; 2011 Apr 07; 46(4):1074-94. PubMed ID: 21315497 [Abstract] [Full Text] [Related]
19. Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs. Prado-Prado FJ, Uriarte E, Borges F, González-Díaz H. Eur J Med Chem; 2009 Nov 07; 44(11):4516-21. PubMed ID: 19631422 [Abstract] [Full Text] [Related]